enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: S-3
Filing Date: 19 Feb 2026Report Date:
Accepted: 19 Feb 2026 02:25 p.m.
Accession Number: 0001193125-26-059479
File Number: 333-293597
Film Number: 26654825
Documents
Primary Document: S-3
Accepted: 19 Feb 2026 02:25 p.m.
0001193125-26-059479-index-headers.html
Last Modified: 19 Feb 2026 02:25 p.m.
0001193125-26-059479-index.html
Last Modified: 19 Feb 2026 02:25 p.m.
0001193125-26-059479.txt
Last Modified: 19 Feb 2026 02:25 p.m.
0001193125-26-059479-xbrl.zip
Last Modified: 19 Feb 2026 02:25 p.m.
engn-ex23_1.htm
Last Modified: 19 Feb 2026 02:25 p.m.
engn-ex4_1.htm
Last Modified: 19 Feb 2026 02:25 p.m.
engn-ex5_1.htm
Last Modified: 19 Feb 2026 02:25 p.m.
engn-ex5_2.htm
Last Modified: 19 Feb 2026 02:25 p.m.
engn_exfilingfees.htm
Last Modified: 19 Feb 2026 02:25 p.m.
engn_exfilingfees_htm.xml
Last Modified: 19 Feb 2026 02:25 p.m.
FilingSummary.xml
Last Modified: 19 Feb 2026 02:25 p.m.
img263254780_0.jpg
Last Modified: 19 Feb 2026 02:25 p.m.
img93391562_0.jpg
Last Modified: 19 Feb 2026 02:25 p.m.
img93391562_1.jpg
Last Modified: 19 Feb 2026 02:25 p.m.
img93391562_2.jpg
Last Modified: 19 Feb 2026 02:25 p.m.
img94315083_0.jpg
Last Modified: 19 Feb 2026 02:25 p.m.
MetaLinks.json
Last Modified: 19 Feb 2026 02:25 p.m.
R1.htm
Last Modified: 19 Feb 2026 02:25 p.m.
R2.htm
Last Modified: 19 Feb 2026 02:25 p.m.
R3.htm
Last Modified: 19 Feb 2026 02:25 p.m.
report.css
Last Modified: 19 Feb 2026 02:25 p.m.
Show.js
Last Modified: 19 Feb 2026 02:25 p.m.